Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
RPG Life Sciences Limited ( (IN:RPGLIFE) ) has shared an announcement.
RPG Life Sciences Limited announced significant strategic decisions following a board meeting on December 15, 2025. The company appointed Mr. Amol Lone as the new Chief Financial Officer, enhancing its leadership with his extensive experience in corporate finance and strategic decision-making. Additionally, the company plans to incorporate a wholly owned subsidiary, RPG Active Pharma Limited, to focus on the API business. This move includes transferring its existing API operations to the new entity and investing up to Rs.105 crore to support its growth and operations, signaling a strategic shift to strengthen its market position in the pharmaceutical sector.
More about RPG Life Sciences Limited
RPG Life Sciences Limited operates in the pharmaceutical industry, focusing on the manufacture and marketing of pharmaceutical products, including active pharmaceutical ingredients (APIs).
Average Trading Volume: 4,453
Technical Sentiment Signal: Buy
Current Market Cap: 38.17B INR
For a thorough assessment of RPGLIFE stock, go to TipRanks’ Stock Analysis page.